Senior insider sale
Chief Financial Officer at NEWAMSTERDAM PHARMA CO N.V. — senior position signals high conviction
$4.64M
200K shares
What this filing means
SOMAIYA MAYUR IAN plans to sell 200K shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $4.64M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/27/2025ACC: 0001968582-25-000052
Officer· Chief Financial Officer
Since Dec 2023
200K
Shares to sell
$4.64M
Approx. market value
200K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
1/27/2025
200KTotal acquired200K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/27/2025 | Stock Option Exercise Cash | 200K | — |
| Total | 200K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
200K
Market value
$4.64M
1/27/2025
Total
Units
200K
Value
$4.64M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/27/2025 | 200K | $4.64M | Nasdaq | Planned |
| Total | 200K | $4.64M | ||